Springer, 2016. — 501 p. This book presents the full range of management techniques and practices used in induction chemotherapy – both systemic and locoregional - by experienced international groups within one accessible volume. It provides the latest information on the pioneering and cutting-edge practices employed in different institutions and documents the advantages of...
Springer Science+Business Media, 2010. — 713 p. This book was put together by eminent and recognized experts in alternative medicine, medical oncology, cancer pharmacology, safety and regulatory issues, and modern cancer research. It is dedicated primarily to the medical community, health care providers, and to medical students. It brings a set of timely, in-depth, and...
Fachmedien: Springer Spektrum, 2015. — 153 p. — ISBN: 978-3-658-10160-2, 978-3-658-10161-9. Hamed Alborzinia uses the biosensor chip to monitor the metabolic and morphological changes in cancer cell lines in real time, particularly: (i) real-time measurements of basic cancer cell metabolism of different cancer cell lines; (ii) a detailed timeline of the metabolic response to...
Oxford University Press, 2010. — 80 p. Although antibiotics are among the most widely used pharmaceuticals, they are also often inappropriately and over-prescribed. Indeed there are increasing predictions that unless we moderate our use of these drugs, bacterial resistance will eventually render them useless. As there are no serious contenders to take the place of antibiotics,...
Wiley-Blackwell, 2017. — 1048 p. — ISBN: 978-1-118-90751-1. The Biology and Therapeutic Application of Mesenchymal Cells comprehensively describes the cellular and molecular biology of mesenchymal stem cells and mesenchymal stromal cells, describing their therapeutic potential in a wide variety of preclinical models of human diseases and their mechanism of action in these...
London: Academic Press, London, 2017. — 294 p. — ISBN: 0128035056, 978-0-12-803505-4, 9780128035412, 0128035412. Conquering RAS: From Biology to Cancer Therapy provides introductory knowledge on how modern RAS biology is taking shape in light of newer technological development. Each chapter is written in a manner that emphasizes simplicity and readability for both new...
ITexLi, 2016. — 188 p. — ISBN: 9535128140 In this book, you can find out how scientists throughout the world deal with this problem. Readers will learn how to engage nature, chemical synthesis, and cell machinery to design new anticancer agents. We are in constant search for new therapeutic options to cure cancer. Nature has already been very generous in providing us different...
CRC Press, 2021. — 328 p. — ISBN: 9781138712423. Differential gene regulation and targeted therapy are the critical aspects of several cancers. This book covers specific gene regulation and targeted therapies for different malignancies. It offers a comprehensive assessment of the transcriptional dysregulation in cancer, and considers some examples of transcriptional regulators...
Academic Press, 2018. — 384 p. — (Cancer Sensitizing Agents for Chemotherapy). — ISBN: 978-0-12-812373-7. This book, Volume Two, focuses on nutraceuticals, the compounds derived from natural sources, which are usually multi-targeted as a means to overcome chemoresistance. This book discusses the role of several compounds related to nutraceuticals and chemoresistance, such as...
Academic Press, 2019. — 429 p. — (Translational Epigenetics). — ISBN: 978-0-12-812494-9. This book is the first to look at epigenetics and chemoprevention together. Although there is numerous scientific data available on how epigenetics can lead to cancer and how chemoprevention can be beneficial in the treatment of, or improvement of quality of life, together they will set an...
Oregon Medical Press, 2001. — 521 p. — ISBN: 0-9648280-1-4 This book is divided into three parts. Parts one and two examine cancer at the cellular level, and cancer at the level of the organism, respectively. After reading parts one and two, the reader will come away with a far greater understanding of what cancer is, how it comes to be, how solid tumors are formed, etc. This...
Humana Press, 2010. — 513 p. Nitric Oxide (NO) is a pleitropic, ubiquitous modulator of cellular functions. Aryl nitrite and glyceryl trinitrate, representative intravasadilators, were introduced as therapeutic agents more than a century ago for relief from acute attacks of angina. The vasodilator action is mediated by the release of NO following treatment. NO has important...
Cham, Switzerland: Springer International Publishing, 2015. — 308 p. — ISBN: 978-3-319-13610-3, 978-3-319-13611-0. Nitric Oxide and Cancer: Pathogenesis and Therapy provides the latest research and applications of nitric oxide (NO) in cancer written by experts in the field. The volume reviews significant advances in the biochemical and molecular biology of NO-mediated effects...
Academic Press, 2017. — 238 p. — (Cancer Sensitizing Agents for Chemotherapy). — ISBN: 978-0-12-811020-1. This book, Volume One is the first book to describe several reviews by authoritative scientists and clinicians on novel findings in the reversal of drug resistant cancers by the combination treatment of Nitric Oxide and sub toxic concentrations of chemotherapeutic drugs...
Humana Press, 2008. — 431 p. — ISBN: 978-1-934115-29-9. Targeted therapies include monoclonal antibodies, cell-mediated immunotherapy, gene immunotherapy, and the development of inhibitors interfering with survival antiapoptotic signaling pathways in cancers. While these novel approaches have significantly improved the outcome of many cancer patients, there remains a major...
Springer Science & Business Media, 2006. — 352 p. Over recent decades, combined modality treatment has drastically improved the cure rates for various malignant tumors. Further progress is expected through the design of sound combinations involving recently developed drugs. The first part of this book summarizes the rationale and the preclinical data for combined treatment with...
5th Edition. - Lippincott Williams & Wilkins, 2011. - 838 p. - Updated to include the newest drugs and those currently in development, Cancer Chemotherapy and Biotherapy, Fifth Edition is a comprehensive reference on the preclinical and clinical pharmacology of anticancer agents. Organized by drug class, the book provides the latest information on all drugs and biological...
Boston: Wolters Kluwer, 2019. — 1004 p. Thoroughly revised and reformatted, the sixth edition of Cancer Chemotherapy, Immunotherapy and Biotherapy reflects recent significant changes in cancer treatment. This newly streamlined edition contains full-color illustrations, more tables for quick reference, and new immunotherapy and molecular targeted therapy content that brings you...
Pan Stanford Publishing, 2019. — 465 p. — ISBN: 9789814774864 This book deals with the emerging concept that certain pathogenic bacteria and viruses, when infecting people with cancer, actively fight tumors, allowing their regression. Although such observations go back more than 100 years, use of specific bacterial strains, or viruses, usually genetically modified with known...
World Scientific Publishing Company, 2017. — 458 p. This unique book deals with both inflammation and cancer in a single source of publication. They are seldom grouped together although it has been known that both diseases are closely associated, particularly in the gastrointestinal tract and liver. As the book touches on two such major areas of diseases in humans, it should be...
Jones & Bartlett Learning, 2015. — 683 p. Principles of Cancer Chemotherapy Chemotherapeutic and Biologic Drugs Guidelines for Chemotherapy and Dosing Modifications Common Chemotherapy Regimens in Clinical Practice Antiemetic Agents for the Treatment of Chemotherapy-Induced Nausea and Vomiting
Jones & Bartlett Learning, 2024. — 970 p. Contributing Authors. Principles of Cancer Chemotherapy. Chemotherapeutic and Biologic Drugs. Guidelines for Chemotherapy and Dosing Modifications. Common Chemotherapy Regimens in Clinical Practice. Antiemetic Agents for the Treatment of Chemotherapy-Induced Nausea and Vomiting.
18th edition. — Jones & Bartlett Learning, 2019. — 655 p. — ISBN: 978-1284144963 Completely revised and updated for 2018, the Physicians' Cancer Chemotherapy Drug Manual is an up-to-date guide to the latest information on standard therapy and recent advances in the field. Written by world-class experts in clinical cancer therapeutics, this essential reference provides a...
21st edition. — Jones & Bartlett Learning, 2021. — 836 p. — ISBN: 9781284230130. Completely revised and updated for 2021, the Physicians’ Cancer Chemotherapy Drug Manual is an up-to-date guide to the latest information on standard therapy and recent advances in the field. Written by world-class experts in clinical cancer therapeutics, this essential reference provides a...
Nova Science Publishers, 2016. — 335 p. This book represents the efforts of young oncologists, haematologists, pharmacists and oncology nurses who are highly motivated and encouraged by the significant development of new effective anticancer drugs. Since the discovery of antimetabolites and alkylating agents in the 1940s and 1950s, many new products have been introduced into...
Humana Press, 2001. — 275 p. The association of matrix metalloproteinases (MMPs)-enzymes that disrupt the body's normal repair functions-with several diseases, including growing and invasive tumors, holds the tantalizing promise that their inhibiton might have therapeutic value. In Matrix Metalloproteinase Inhibitors in Cancer Therapy, cutting-edge investigators review the...
CRC Press, Taylor & Francis Group, 2017. — 204 p. — (Chapman & HALL/CRC. Mathematical and Computational Biology Series) — ISBN: 1466551348. Physical oncology has the potential to revolutionize cancer research and treatment. The fundamental rationale behind this approach is that physical processes, such as transport mechanisms for drug molecules within tissue and forces...
Cham, Switzerland: Humana Press, 2015. — 591 p. — (Cancer Drug Discovery and Development 83). — ISBN: 978-3-319-14150-3, 978-3-319-14151-0. PARP Inhibitors for Cancer Therapy provides a comprehensive overview of the role of PARP in cancer therapy. The volume covers the history of the discovery of PARP (poly ADP ribose polymerase) and its role in DNA repair. In addition, a...
Cham, Switzerland: Springer, 2015. — 292 p. — ISBN: 3319191438, 9783319191430. Provides a comprehensive review of the most current findings on the efficacy of bioactive essential oils as a possible therapeutic for cancer Appeals to cancer researchers and those interested in natural products, medicinal chemistry and pharmacology Explores the chemical and biological mechanisms of...
Springer, 2013. — 659 p. This book is a comprehensive handbook designed for quick reference by medical oncologists on the side-effects of cancer therapy drugs, including the chemotherapeutic drugs. Organised by organ system, it will list the toxicity, side-effects and measures of prevention pertaining to each type of drug used in cancer therapy. The most dangerous side-effects...
2nd edition. — Springer, 2018. — 512 p. — ISBN: 978-3-319-70252-0 This is the second edition of a well-received book that reflects the state of the art in cancer medical therapies and their side-effects, including immunotherapy and chemotherapeutic drugs. All chapters have been fully updated to include all the latest progress in drug discovery such as targeted therapies for...
Springer New York, 2014. — 256 p. Cancer incidences increase in people living with HIV/AIDS. Over 2 million people currently live with HIV/AIDS in the US. This number will increase as HAART prolongs the average lifespan and as (at least in some states) the number of new HIV infections increase again. As this population ages their incidence rates for cancer will increase, as...
Springer, 2013. — 952 p. Image-Guided Cancer Therapy: A Multidisciplinary Approach provides clinicians with in-depth coverage of the growing, dynamic field of interventional oncology. Combining the knowledge of expert editors and authors into one powerhouse reference, this book looks at tumor ablation, HIFU, embolic therapies, emerging technologies, and radiation therapy...
Demos Medical Publishing, 2020. — 301 p. — ISBN: 978-0-8261-6203-8. Cancer Pharmacology: An Illustrated Manual of Anticancer Drugs provides a one-stop guide to the essential basic and clinical science of all the effective, life-prolonging drug therapies in oncology. From traditional cytotoxic agents to targeted genomic, epigenomic, hormonal, and immunotherapeutic agents, this...
Humana Press, 2009. — 296 p. Supportive care of the cancer patient begins with the diagnosis of cancer and terminates with the end of life. The supportive care is for symptoms related to the cancer and/or its treatment; physical, psychosocial and emotional issues associated with the cancer. Patients with cancer, in general, are living longer. Even those with advanced,...
Springer, 2018. — 402 p. — (Resistance to Targeted Anti-Cancer Therapeutics 17). In this book, expert authors revisit the most relevant aspects of these therapies, with special emphasis on molecular mechanisms and clinical effects of resistance. The knowledge of the underlying mechanisms involved in tumor resistance to target therapies is of paramount importance because they...
2nd Edition. — Humana Press, 2014. — 828 p. There are many steps on the road from discovery of an anticancer drug to securing its final approval by the Food and Drug Administration. In this thoroughly updated and expanded second edition of the Handbook of Anticancer Pharmacokinetics and Pharmacodynamics, leading investigators synthesize an invaluable overview of the...
Demos Medical, 2011. — 256 p. Manual of Cancer Treatment Recovery presents the first comprehensive program to guide the recovery from cancer and its treatment. The Manual helps you, other practitioners, and your staff members plan early intervention and promote healing right from the start, before distressing symptoms begin. Manual of Cancer Treatment Recovery teaches how to...
Demos Medical Publishing, 2011. — 228 p. Manual of Cancer Treatment Recovery presents the first comprehensive program to guide the recovery from cancer and its treatment. The Manual helps you, other practitioners, and your staff members plan early intervention and promote healing right from the start, before distressing symptoms begin. Manual of Cancer Treatment Recovery...
Springer International Publishing, Cham, Switzerland, 2016, 188 p., ISBN: 978-3-319-46090-1, 978-3-319-46091-8. Resistance to Targeted Anti-Cancer Therapeutics. The volume will provide readers with a primer on tyrosine kinase signaling and its importance in cancer. The reader will be first introduced to common denominators of small-molecule and antibody-derived inhibitors, and...
Springer, 2019. — 490 p. — ISBN: 978-3-030-28890-7 This book is a state-of-the-art overview of cancer regional therapy (CRT) for the surgeons and interventional radiologists active in CRT development and research. The goals of this book are 1) to review the theory and practice of cancer regional therapies including pharmacology, devices, techniques, and workflow, 2) illustrate...
Springer, 2019. — 1711 p. — ISBN: 978-3-030-28891-4 This book is a state-of-the-art overview of cancer regional therapy (CRT) for the surgeons and interventional radiologists active in CRT development and research. The goals of this book are 1) to review the theory and practice of cancer regional therapies including pharmacology, devices, techniques, and workflow, 2) illustrate...
Adis, 2015. — 410 p. — ISBN: 978-3-319-12252-6, 978-3-319-12253-3. Presents multi-targeted approach to treating cancer Provides rationale for treatment Presents targeted approaches to treating, preventing and managing cancer In this book, clinicians and basic scientists from USA, India, and other countries discuss the rationales and clinical experiences with targeted approaches...
2nd Edition. — CRC Press, 2014. — 485 p. Since the last edition of this book, major advances have been made in our understanding of key pathways that control tumor progression. This has led to the development of new anticancer agents that have the ability to block the activity of proteins involved in neoplastic cell development and proliferation. Targeted Therapies in Oncology,...
Springer US, 2009. — 380 p. — ISBN: 978-0-387-77103-8. Late Effects of Treatment for Brain Tumors reviews the development of the medical team's awareness of late effects of brain tumor treatment and an overview of brain tumor survivorship. It reviews the late effects by topic and by organ systems, educates, and provides guidelines for follow up and interventions for patient...
London: Academic Press, 2015. — 721 p. — (Translational Epigenetics Series). — ISBN: 0128002069, 978-0-12-800206-3. Epigenetic Cancer Therapy unites issues central to a translational audience actively seeking to understand the topic. It is ideal for cancer specialists, including oncologists and clinicians, but also provides valuable information for researchers, academics,...
2nd edition. — Academic Press, 2023. — 773 p. — (Translational Epigenetics Series). — ISBN: 978-0-323-91367-6. Epigenetic Cancer Therapy, Second Edition provides a comprehensive discussion of healthy and aberrant epigenetic biology, along with discoveries to improve our understanding of cancer epigenetics and therapeutics. The book encompasses large-scale intergovernmental...
Cham, Switzerland: Springer International Publishing, 2015. — 490 p. — ISBN: 978-3-319-20749-0, 978-3-319-20750-6. Examines the roles and functions of sphingolipids in the development, progression and treatment of various cancers Explores the use of innovative approaches for quantitative analysis and imaging which could have the potential benefit of helping to develop novel...
CRC Press, 2018. — 314 p. This book provides researchers and practitioners with a unique collection of current research on the role of vitamins and micronutrients in cancer prevention and treatment. New theories are discussed, including a hypothesis that dietary factors may protect against genetically predisposed cancers. Mechanisms by which different vitamins and minerals...
Springer, 2013. — 503 p. — ISBN: 978-1-60327-968-0. Cancer remains a major cause of death worldwide. With modern therapy, millions of patients can expect (or at least hope) to be cured. With the passage of time, a proportion of these cancer survivors experience recurrence. Some die and some are rescued by further interventions. Some sustain complications of treatment which are...
Humana Press, 2002. — 423 p. Millions of people are now successfully using hormone antagonists for the treatment of endocrine-dependent cancers. In Hormone Therapy in Breast and Prostate Cancer, many of today's leading researchers and clinicians describe the principles underlying these targeted treatments, assess the actions of new and established agents, and illustrate the new...
4th ed. — Lippincott Williams & Wilkins, 2016. — 648 p. — ISBN: 978-1-469-88997-9. This unique, full-color reference offers a total team approach to radiation oncology treatment planning, incorporating the newest imaging techniques and offering a comprehensive discussion of clinical, physical, biological and technical aspects. A clear focus on the application of physical and...
9th edition. — Wolters Kluwer, 2016. — 954 p. — ISBN: 9781496305558 For more than 30 years, Skeel’s Handbook of Cancer Therapy (formerly Handbook of Cancer Chemotherapy ) has been the resource of choice for current, reliable information on cancer treatment for most adults. The 9th Edition reflects recent significant advances in the systemic treatment of cancer, including...
Springer Science+Business Media, Dordrecht, Netherlands, 2016, 276 p., ISBN: 978-94-024-0842-3, 978-94-024-0844-7. Presents comprehensive charts of important discoveries of scientific endeavours on cancer research. Includes timelines and conceptual cartoons for wide spectrum of anticancer drugs. Provides a novel perspective for the research on cell network according to the...
Humana Press, 2013. — 248 p. — (Cancer Drug Discovery and Development). This volume will cover the natural products as they relate to cancer chemotherapy. The topics will include history and current status , recent launches, new clinical candidates and approved drugs directly derived from natural products, current and future cancer target opportunities for natural products,...
Nova Science Publishers, 2014. — 164 p. Since the year 2000, exciting developments in cancer therapy have occurred. For decades in the 20th century, the hallmark of medical treatment for cancer had been cytotoxic chemotherapy, with drugs targeting rapidly dividing cells, including cancer cells but also certain normal tissues. As a result, many patients experienced the "classic"...
Springer Netherlands, 2014. — 344 p. Microwave ablation is a simple, affordable, and highly precise technique. After its successful application in treating liver tumors, it is now widely used to combat renal tumors, adrenal tumors, thyroid nodes, uterine fibroids and other solid tumors. This book presents 40 successful cases of treating these diseases. A series of picture...
Humana Press, 2008. — 680 p. — (Contemporary Hematology) — ISBN: 978-1-934115-82-4 Therapeutic options for patients with myeloma have radically changed over the past ten years. Myeloma Therapy: Pursuing the Plasma Cell provides updated various treatment options for patients with myeloma, with focus on the emerging and speculative aspects of myeloma therapy. Written by clearly...
Springer Science & Business Media, 2009. — 392 p. The extravasation of cytotoxic agents can result in severe local tissue damage and medical emergencies during tumour therapy. This revised compendium is intended to help clinicians assess any situation speedily and with certainty. The general section of the book includes topics such as predisposition, prevention, type of harm,...
2nd edition. — Springer Science & Business Media, 2009. — 392 p. The extravasation of cytotoxic agents can result in severe local tissue damage and medical emergencies during tumour therapy. This revised compendium is intended to help clinicians assess any situation speedily and with certainty. The general section of the book includes topics such as predisposition, prevention,...
Springer Science+Business Media, New York, 2017. — 1087 p. — (Springer Reference) — ISBN: 1441907165. In the past decade, we have experienced an explosion of new information about cancer therapeutic targets. Many of the targets have been validated by the discovery and approval of new medicines which have been approved for the treatment of cancer. On the heels of these...
Academic Press, 2001. — 425 p. Tumor Suppressing Viruses, Genes, and Drugs profiles the new generation of cancer treatments now in development. The book examines the innovative new approaches of viral, gene, and signal therapies that promise to replace or enhance conventional methods such as surgery, radiation, and chemotherapy. The timely information presented by this book...
Springer, 2019. — 129 p. The book provides invaluable information on the interesting and compelling field of cancer drug safety. Identifying and understanding high-priority policy issues and key pharmacovigilance strategies is of paramount importance. In this volume, outstanding and original chapters provide an overview and synthesis of the latest thoughts and findings relating...
Springer, 2009. — 372 p. — ISBN: 978-0-387-89444-7 An estimated 1.5 million patients in the United States are diagnosed with cancer every year and over half-a-million individuals die of the disease. Since the vast majority of the deaths occur after medical intervention with anticancer therapy, both conventional chemotherapy and novel targeted therapy, it can be concluded that...
Springer International Publishing AG, 2018. — 281 p. — ISBN: 3319551124. This book provides a comprehensive overview of the clinical use of irreversible electroporation (IRE) - better known by its commercial name, NanoKnife - which is one of the most exciting new needle-guided cancer treatments. The coverage includes the history of IRE, general technique, preclinical research,...
Springer International Publishing AG, 2018. — 281 p. — ISBN: 3319551124. This book provides a comprehensive overview of the clinical use of irreversible electroporation (IRE) - better known by its commercial name, NanoKnife - which is one of the most exciting new needle-guided cancer treatments. The coverage includes the history of IRE, general technique, preclinical research,...
Springer New York, 2014. — 322 p. Despite the advances in conventional, novel agent and high dose chemotherapy multiple myeloma (MM) remains incurable. to overcome resistance to current therapies and improve patient outcome, novel biologically-based treatment approaches are being developed. Current translational research in MM focusing on the development of molecularly-based...
Academic Press, 2019. — 207 p. — (Cancer Sensitizing Agents for Chemotherapy). — ISBN: 978-0-12-817661-0. This book focuses on overriding the resistance from chemotherapeutic drugs with a broader range of treatment options. It particularly focuses on stroma, tumor microenvironment, stem cells, stellate cells, transcription factors, growth factors, and important signaling...
1st Ed. Wiley, 2007. — 272 p Introduction: The Nature of the Beast Mario’s Story The First Hours The Plan Leukemia and Cancer Chemotherapy The Final Treatment Plan for Mario The Risk of Chemotherapy Resistance Three Critical Smart Drugs: Nursing Care, Psychology,and Social Work Mario’s Future Joan’s Story A Pleasant Summer Day Bad News An Initial Plan The Surgical Plan The...
Springer, 2020. — 266 p. — (Medical Radiology: Diagnostic Imaging). — ISBN ISBN 978-3-030-31170-4. This book is a detailed guide to therapy response imaging in cancer patients that fully takes into account the revolutionary progress and paradigm shift in treatment approaches for advanced disease. The opening chapters describe the role of imaging as a “common language” for tumor...
5th edition. — Wolters Kluwer, 2012. — 847 p. — ISBN: 978-1-451-10145-4 Perry’s The Chemotherapy Source Book , now in its fifth edition, provides information on the choice of chemotherapeutic agents, the use of combination chemotherapy, and the toxicity of individual drugs. Organized by site, this is the only book of its kind to focus strictly on the clinical practice of...
Springer Science & Business Media, 2007. — 476 p. Successful cancer chemotherapy relies heavily on the application of various deoxynucleoside analogs. Since the very beginning of modern cancer chemotherapy, a number of antimetabolites have been introduced into the clinic and subsequently applied widely for the treatment of many malignancies, both solid tumors and hematological...
Bentham Science Publishers, 2017. — 220 p. Cancer is a major cause of deaths all around the globe. Although numerous anticancer drugs are available, most of them are expensive and have serious side effects. Natural compounds are usually non-toxic and inexpensive. Many such compounds have been identified and explored for their health benefits for centuries, and several...
Bentham Science Publishers, 2016. — 252 p. — ASIN B01M8NB6WW. The inhibition of angiogenesis is an effective mechanism of slowing down tumor growth and malignancies. The process of induction or pro-angiogenesis is highly desirable for the treatment of cardiovascular diseases, wound healing disorders, etc. Efforts to understand the molecular basis, both for inhibition and...
Springer International Publishing, 2015. — 248 p. — (Resistance to Targeted Anti-Cancer Therapeutics 5). — ISBN: 978-3-319-12729-3, 978-3-319-12730-9. Explores mechanisms of action in PDT, the relationship between PDT cytotoxicity and cellular changes Discusses the development of new technological advances in PDT for cancer Offers strategic approaches to reduce multi-drug...
Springer Science & Business Media, 2010. — 568 p. Presenting a holistic and abstract perspective of tumors, this volume aims to provide personalized diagnostic and therapeutic strategies for the control of metastatic tumor disease. Readers will find ways to record tumor biology that are based on different sciences, in addition to other strategies.
De Gruyter, 2014. — 252 p. Peritoneal dissemination is a common route of cancer metastasis. The benefit of administering chemotherapy directly into the peritoneal cavity is supported by preclinical and pharmacokinetic data. In comparison to intravenous (IV) treatment, intraperitoneal (IP) administration results in a several-fold increase in drug concentration within the...
Springer, 2013. — 311 p. The literature on the late effects of cancer treatment is widely scattered in different journals since all major organ systems are affected and management is based on a variety of medical and surgical treatments. The aim of "ALERT – Adverse Late Effects of Cancer Treatment" is to offer a coherent multidisciplinary approach to the care of cancer...
Springer Berlin Heidelberg, 2016. — 700 p. The literature on the late effects of cancer treatment is widely scattered in different journals since all major organ systems are affected and management is based on a variety of medical and surgical treatments. The aim of "ALERT – Adverse Late Effects of Cancer Treatment" is to offer a coherent multidisciplinary approach to the care...
New York: Humana Press, 2015. — 269 p. — (Current Clinical Pathology). — ISBN: 978-1-4939-2046-4, 978-1-4939-2047-1. This volume provides readers a comprehensive and state-of-the-art overview about the range of applications of targeted therapies for solid tumors. The sections of the book have been structured to review the oncogene addicted tumors, the pharmacology and clinical...
Springer, 2014. — 349 p. Since the discovery of microRNAs (miRNAs) some twenty years ago by Victor Ambros, David Baulcombe and Gary Ruvkun, these three scientists worked to uncover the mystery of miRNA, the small segments of nucleotides that silence genes. While studying the development of the nematode worm, Ambros and Ruvkun discovered miRNA in animals, while Baulcombe...
Humana Press Inc., 2007. — 455 p. — ISBN: 978-1-58829-672-6. Regional cancer therapies remain important options in the management of malignant disease, in spite of the venue of more targeted agents for systemic therapies. New technologies and better guidance systems for radiofrequency ablation and intrastitial laser therapies, highly selective intravascular approaches with...
CRC Press, 2018. — 185 p. This book is an introduction to cancer treatment, the basics of radio- and chemotherapy, drug actions, the eradication of cancer cells, and the origins and persistence of pharmacological and toxicological effects of drugs. It further provides ideas for research based on knowledge of cancer metastasis, invasive and molecular pathways, and diagnosis and...
Humana Press, 2005. — 343 p. Bone metastasis occurs in 60 to 85% of all breast, prostate, and lung cancer patients and is responsible for increasing morbidity. In Bone Metastasis: Experimental and Clinical Therapeutics, leading bone metastasis experts from around the world explain the molecular underpinnings of the process, review current treatment approaches, and outline...
Springer, 2017. — 222 p. Dichotomies in medicine are common, but it is nowhere more clearly demonstrated than in radiation exposure either used in diagnoses or in treatment as compared to excessive or unwanted radiation exposure either locally or systematically. Other dichotomies demonstrated in radiation injury include the separation between acute and late radiation damage,...
Fachmedien: Springer, 2015. — 126 p. — ISBN: 978-3-658-09504-8, 978-3-658-09505-5. Georg Stuebinger verifies each of the 24 most common and deadliest cancer diseases worldwide including well-established and potential risk factors resp. important symptoms by using current literature and comprehensive scientific studies with a direct relation to the impact of various parameters...
CRC Press, 2003. — 415 p. The growth in chemotherapy has led to a great need for all those involved to be familiar with safe procedures based on best evidence-based practice. Practical Chemotherapy: a multidisciplinary guide is a comprehensive and straightforward guide describing over 70 widely used chemotherapy regimens, helping to make their prescription and administration...
CRC Press, 2017. — 117 p. This comprehensive and useful handbook represents a definitive up-to-date compendium of key in vitro bioassay methods that are employed to quantify and validate the anticancer activity of a drug candidate before it makes its way in to animal or clinical trials. In Vitro Bioassay Techniques for Anticancer Drug Discovery and Development covers the...
World Scientific, 2009. — 201 p. — ISBN: 978-981-283-579-6 This very provocative book takes the reader on a “think-out-of-the-box” journey through the development of a treatment regimen for multiple myeloma called “dtZ”. It is a firsthand account of how more than 50 patients with myeloma were given a non-toxic, precisely-targeted, anti-cancer treatment that was specifically...
M.Teppone, R.Avakyan. Extremely High-Frequency Therapy in Oncology. - The Journal of Alternative and Complementary Medicine. 2010, 16(11): 1211-1216. Objective: This article represents a review of the literature, mainly from Russian sources, dealing with the therapeutic application of low-intensity electromagnetic radiation in the millimeter band applied to experimental and...
Hoboken, New Jersey: Wiley-Blackwell, 2015. — 400 p. — ISBN: 400-978-1-118-46857-9, 1118468570. Targeted Therapy in Translational Cancer Research for the Translational Oncology series provides a comprehensive overview of recent developments in our understanding of tumor biology, elucidates the roles of targets and pathways involved in carcinogenesis, and describes current...
Springer, 2018. — 183 p. — ISBN: 978-3-319-61871-5. The management of multiple myeloma (MM) has evolved tremendously over the last decade, from being an orphan disease with limited treatment options to a disease that can be chronically managed for most patients. The knowledge of the heterogenous disease biology and development of novel drug classes (immunomodulatory drugs,...
2nd edition. — Hoboken: Wiley, 2024. — 453 p. Demystifying the science behind new cancer treatments. An accessible guide written in everyday language for nurses and non-scientists. Written by gifted communicator Elaine Vickers, Ph.D., this is the second edition of her popular book, first published in 2018. Since then, hundreds of readers have benefited from Elaine's informal...
Wiley-Blackwell, 2018. — 1106 p. — ISBN: 978-1-119-12682-9 Written for anyone who encounters cancer patients, cancer data or cancer terminology, but have no more than a passing knowledge of cell biology. A Beginner's Guide to Targeted Cancer Treatments provides an understanding of how cancer works and the many new treatments available.Using over 100 original illustrations, this...
Wiley-Blackwell, 2018. — 346 p. — ISBN: 978-1-119-12679-9 Written for anyone who encounters cancer patients, cancer data or cancer terminology, but have no more than a passing knowledge of cell biology. A Beginner's Guide to Targeted Cancer Treatments provides an understanding of how cancer works and the many new treatments available.Using over 100 original illustrations, this...
Springer, 2019. — 285 p. — (Cancer Treatment and Research) — ISBN: 978-3-030-16390-7 This book presents the latest advances in precision medicine in some of the most common cancer types, including hematological, lung and breast malignancies. It also discusses emerging technologies that are making a significant impact on precision medicine in cancer therapy. In addition to...
McGraw-Hill, 2005. — 228 p. Inspired by the experience of art therapists who have pioneered work with people with cancer and including those who have experienced this devastating illness at first hand, this book acknowledges the outstanding work of the Corinne Burton Trust which has supported the development of art therapy services in hospices and clinics throughout the United...
Springer, 2016. — 139 p. — ISBN: 978-3-319-30574-5 This concise text provides a complete overview of alternating electric fields therapy -- also known as tumor treating fields -- for glioblastoma and other types of solid tumor malignancies. Readers are given a fundamental understanding of this novel anti-cancer treatment modality by learning from clinical trial data as well as...
Springer Publishing Company, 2016. — 192 p. Cancer Pharmacology and Pharmacotherapy Review is the first book devoted entirely to providing the 'must-know' facts on each cancer agentóincluding their pharmacokinetics, FDA-approved indications, toxicity, interactions, and other important information that is commonly found on board examinations and essential for any clinician or...
Springer Publishing Company, 2016. — 192 p. Cancer Pharmacology and Pharmacotherapy Review is the first book devoted entirely to providing the 'must-know' facts on each cancer agentóincluding their pharmacokinetics, FDA-approved indications, toxicity, interactions, and other important information that is commonly found on board examinations and essential for any clinician or...
Springer International Publishing, Switzerland, 2016, 141 p., ISBN: 978-3-319-42738-6, 978-3-319-42740-9. Current Cancer Research. Focuses solely on autophagy as a target in cancer therapy, for the first time. Covers a wide range of topics such as autophagy as a therapeutic target in cancer, autophagy modulators as cancer therapeutic agents, implications of micro-RNA-regulated...
Comments